AHRQ Stats: Adverse Drug Events Involving Hypoglycemic Agents

https://www.ahrq.gov/sites/default/files/wysiwyg/research/findings/nhqrdr/chartbooks/patientsafety/2023qdr-patient-safety-chartbook-final.pdf#page=71 In 2021, 7.5 percent of Hispanic patients, 6.6 percent of Black patients, 6.2 percent of patients with an “other” or unknown race, and 4.0 percent of White patients experienced adverse inpatient events involving hypoglycemic agents, which are used to control blood sugar levels in diabetic patients. (Source: AHRQ 2024